Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 36 | 2024 | 270 | 15.220 |
Why?
|
| Asthma | 47 | 2025 | 1003 | 12.100 |
Why?
|
| Nebulizers and Vaporizers | 20 | 2024 | 57 | 6.630 |
Why?
|
| Patient Readmission | 14 | 2024 | 393 | 6.500 |
Why?
|
| Health Literacy | 12 | 2022 | 73 | 5.730 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 370 | 4.520 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.240 |
Why?
|
| Hospitalization | 21 | 2024 | 926 | 4.060 |
Why?
|
| Inpatients | 16 | 2024 | 331 | 3.760 |
Why?
|
| Anti-Asthmatic Agents | 10 | 2025 | 79 | 3.290 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 21 | 2.660 |
Why?
|
| Administration, Inhalation | 19 | 2025 | 193 | 2.340 |
Why?
|
| Humans | 121 | 2025 | 92303 | 1.780 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.690 |
Why?
|
| Telemedicine | 6 | 2024 | 213 | 1.650 |
Why?
|
| Surveys and Questionnaires | 14 | 2025 | 2729 | 1.520 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.430 |
Why?
|
| Length of Stay | 4 | 2024 | 791 | 1.250 |
Why?
|
| Child | 26 | 2025 | 7303 | 1.190 |
Why?
|
| Quality of Health Care | 5 | 2024 | 390 | 1.170 |
Why?
|
| Female | 56 | 2025 | 47894 | 1.040 |
Why?
|
| Patient Discharge | 4 | 2023 | 339 | 1.030 |
Why?
|
| Self-Management | 3 | 2024 | 43 | 1.030 |
Why?
|
| Male | 53 | 2025 | 43924 | 1.020 |
Why?
|
| Parents | 5 | 2020 | 296 | 1.000 |
Why?
|
| Equipment Failure | 2 | 2020 | 123 | 0.980 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 0.970 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 38 | 0.950 |
Why?
|
| Chicago | 12 | 2024 | 1466 | 0.930 |
Why?
|
| United States | 21 | 2024 | 7346 | 0.900 |
Why?
|
| Vision Disorders | 2 | 2016 | 72 | 0.890 |
Why?
|
| Minority Groups | 5 | 2019 | 150 | 0.880 |
Why?
|
| Health Status Disparities | 2 | 2017 | 201 | 0.870 |
Why?
|
| Patient Participation | 3 | 2024 | 227 | 0.870 |
Why?
|
| Hospitals | 4 | 2023 | 313 | 0.840 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 130 | 0.830 |
Why?
|
| Community Health Workers | 2 | 2022 | 38 | 0.800 |
Why?
|
| Patients | 3 | 2020 | 106 | 0.800 |
Why?
|
| Educational Measurement | 2 | 2016 | 235 | 0.790 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 1775 | 0.780 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 16 | 0.780 |
Why?
|
| Quality of Life | 7 | 2025 | 1744 | 0.760 |
Why?
|
| Adult | 24 | 2025 | 27535 | 0.760 |
Why?
|
| Education, Medical, Undergraduate | 4 | 2025 | 183 | 0.750 |
Why?
|
| Middle Aged | 26 | 2024 | 27043 | 0.740 |
Why?
|
| Quality Improvement | 4 | 2020 | 474 | 0.740 |
Why?
|
| Mass Screening | 3 | 2017 | 675 | 0.740 |
Why?
|
| Students, Medical | 5 | 2025 | 433 | 0.720 |
Why?
|
| Women | 1 | 2021 | 26 | 0.700 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 630 | 0.690 |
Why?
|
| Awards and Prizes | 1 | 2021 | 36 | 0.690 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 657 | 0.680 |
Why?
|
| Research Support as Topic | 1 | 2021 | 87 | 0.680 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.680 |
Why?
|
| Drug Misuse | 1 | 2020 | 2 | 0.680 |
Why?
|
| Research Personnel | 1 | 2021 | 74 | 0.670 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 281 | 0.670 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 560 | 0.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1212 | 0.660 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 7 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1073 | 0.650 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 542 | 0.640 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 217 | 0.630 |
Why?
|
| Risk Factors | 8 | 2024 | 5705 | 0.630 |
Why?
|
| Disease Management | 3 | 2020 | 340 | 0.620 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1920 | 0.610 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 176 | 0.600 |
Why?
|
| Natural Language Processing | 1 | 2019 | 43 | 0.600 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2025 | 74 | 0.580 |
Why?
|
| Adolescent | 11 | 2024 | 9491 | 0.580 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 743 | 0.560 |
Why?
|
| Schools | 2 | 2018 | 79 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 760 | 0.560 |
Why?
|
| Attitude to Health | 1 | 2018 | 221 | 0.540 |
Why?
|
| Social Media | 1 | 2019 | 100 | 0.540 |
Why?
|
| Aged | 16 | 2024 | 19952 | 0.540 |
Why?
|
| Betacoronavirus | 1 | 2020 | 270 | 0.530 |
Why?
|
| Prospective Studies | 11 | 2024 | 4469 | 0.530 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.520 |
Why?
|
| Accidental Falls | 1 | 2016 | 49 | 0.510 |
Why?
|
| Health Policy | 5 | 2018 | 190 | 0.500 |
Why?
|
| Delirium | 2 | 2016 | 73 | 0.490 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 21 | 0.490 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2025 | 278 | 0.490 |
Why?
|
| Spirometry | 4 | 2023 | 69 | 0.480 |
Why?
|
| Psychometrics | 2 | 2023 | 335 | 0.480 |
Why?
|
| Data Collection | 3 | 2013 | 379 | 0.480 |
Why?
|
| Disease Progression | 1 | 2020 | 1504 | 0.480 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 443 | 0.480 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.470 |
Why?
|
| Retrospective Studies | 8 | 2024 | 9679 | 0.470 |
Why?
|
| Patient Care Team | 2 | 2018 | 296 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 329 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 315 | 0.470 |
Why?
|
| Patient Advocacy | 1 | 2015 | 54 | 0.460 |
Why?
|
| Medicare | 3 | 2024 | 440 | 0.460 |
Why?
|
| Pediatrics | 1 | 2019 | 368 | 0.450 |
Why?
|
| Comorbidity | 3 | 2024 | 985 | 0.450 |
Why?
|
| HIV Infections | 1 | 2023 | 895 | 0.440 |
Why?
|
| Trust | 2 | 2016 | 98 | 0.430 |
Why?
|
| Guideline Adherence | 4 | 2024 | 239 | 0.420 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 67 | 0.410 |
Why?
|
| Logistic Models | 3 | 2022 | 1239 | 0.410 |
Why?
|
| Heart Failure | 1 | 2023 | 1346 | 0.410 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 109 | 0.400 |
Why?
|
| Hospital Medicine | 2 | 2023 | 24 | 0.400 |
Why?
|
| Internship and Residency | 4 | 2012 | 1083 | 0.400 |
Why?
|
| Biomedical Research | 3 | 2024 | 404 | 0.400 |
Why?
|
| Formoterol Fumarate | 2 | 2025 | 10 | 0.380 |
Why?
|
| Physicians | 3 | 2020 | 693 | 0.370 |
Why?
|
| Family | 1 | 2013 | 324 | 0.370 |
Why?
|
| Urban Population | 4 | 2018 | 229 | 0.370 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 505 | 0.360 |
Why?
|
| Cognition | 1 | 2015 | 603 | 0.350 |
Why?
|
| Schools, Medical | 4 | 2024 | 137 | 0.350 |
Why?
|
| Child, Preschool | 6 | 2023 | 3803 | 0.350 |
Why?
|
| Aging | 1 | 2015 | 739 | 0.350 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.340 |
Why?
|
| Societies, Medical | 3 | 2024 | 596 | 0.330 |
Why?
|
| Prevalence | 4 | 2024 | 1294 | 0.330 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2024 | 52 | 0.330 |
Why?
|
| Cost Savings | 2 | 2022 | 72 | 0.320 |
Why?
|
| Chronic Disease | 3 | 2023 | 965 | 0.320 |
Why?
|
| Self Administration | 3 | 2018 | 72 | 0.320 |
Why?
|
| Feasibility Studies | 4 | 2020 | 800 | 0.320 |
Why?
|
| Self Care | 4 | 2016 | 169 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2025 | 886 | 0.310 |
Why?
|
| Poverty | 3 | 2019 | 189 | 0.310 |
Why?
|
| Teaching | 1 | 2010 | 146 | 0.300 |
Why?
|
| Time Factors | 4 | 2024 | 5430 | 0.300 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 85 | 0.300 |
Why?
|
| Educational Status | 2 | 2023 | 197 | 0.290 |
Why?
|
| Sex Factors | 2 | 2024 | 1095 | 0.280 |
Why?
|
| Equipment Design | 2 | 2021 | 420 | 0.280 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 55 | 0.280 |
Why?
|
| Students | 2 | 2018 | 174 | 0.270 |
Why?
|
| Self Concept | 2 | 2019 | 135 | 0.260 |
Why?
|
| Registries | 2 | 2024 | 904 | 0.260 |
Why?
|
| Internet | 2 | 2020 | 330 | 0.260 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 611 | 0.260 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 452 | 0.240 |
Why?
|
| Curriculum | 2 | 2024 | 582 | 0.240 |
Why?
|
| Communication Barriers | 2 | 2015 | 31 | 0.240 |
Why?
|
| Qualitative Research | 2 | 2018 | 325 | 0.230 |
Why?
|
| Medical History Taking | 1 | 2025 | 85 | 0.230 |
Why?
|
| Program Evaluation | 2 | 2020 | 315 | 0.230 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2025 | 25 | 0.230 |
Why?
|
| Cost Sharing | 1 | 2024 | 17 | 0.230 |
Why?
|
| Electronic Health Records | 3 | 2017 | 364 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2024 | 105 | 0.220 |
Why?
|
| Checklist | 2 | 2016 | 68 | 0.220 |
Why?
|
| Control Groups | 1 | 2023 | 16 | 0.210 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 21 | 0.210 |
Why?
|
| Health Promotion | 2 | 2024 | 168 | 0.210 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.210 |
Why?
|
| Sex Distribution | 2 | 2021 | 173 | 0.200 |
Why?
|
| Health Equity | 1 | 2024 | 98 | 0.190 |
Why?
|
| Health Expenditures | 2 | 2024 | 97 | 0.190 |
Why?
|
| Polysomnography | 1 | 2022 | 151 | 0.190 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 154 | 0.190 |
Why?
|
| Young Adult | 4 | 2024 | 6628 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 871 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 88 | 0.180 |
Why?
|
| Syndrome | 1 | 2022 | 449 | 0.180 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 39 | 0.180 |
Why?
|
| Exercise | 1 | 2024 | 335 | 0.180 |
Why?
|
| Cross Infection | 2 | 2013 | 153 | 0.180 |
Why?
|
| Exercise Therapy | 1 | 2021 | 88 | 0.180 |
Why?
|
| Feedback | 1 | 2021 | 137 | 0.180 |
Why?
|
| Insurance, Health | 2 | 2020 | 172 | 0.180 |
Why?
|
| Physician's Role | 2 | 2013 | 179 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3773 | 0.170 |
Why?
|
| Focus Groups | 2 | 2018 | 186 | 0.170 |
Why?
|
| Needs Assessment | 2 | 2018 | 159 | 0.170 |
Why?
|
| School Nursing | 1 | 2019 | 3 | 0.160 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 127 | 0.160 |
Why?
|
| Machine Learning | 1 | 2022 | 298 | 0.160 |
Why?
|
| Primary Health Care | 2 | 2020 | 362 | 0.160 |
Why?
|
| Mentors | 2 | 2023 | 94 | 0.160 |
Why?
|
| Prescription Fees | 1 | 2018 | 10 | 0.150 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 43 | 0.150 |
Why?
|
| Cause of Death | 1 | 2020 | 270 | 0.150 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.150 |
Why?
|
| Research Design | 2 | 2024 | 600 | 0.150 |
Why?
|
| Nurses | 1 | 2018 | 41 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2018 | 40 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 996 | 0.150 |
Why?
|
| Disabled Children | 1 | 2018 | 44 | 0.150 |
Why?
|
| Congresses as Topic | 1 | 2019 | 120 | 0.140 |
Why?
|
| Allergens | 1 | 2019 | 189 | 0.140 |
Why?
|
| Counseling | 2 | 2010 | 171 | 0.140 |
Why?
|
| Awareness | 1 | 2018 | 89 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 105 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2021 | 2369 | 0.140 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 276 | 0.140 |
Why?
|
| Videoconferencing | 1 | 2017 | 16 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 6916 | 0.140 |
Why?
|
| Inhalation | 1 | 2017 | 31 | 0.140 |
Why?
|
| Lung | 2 | 2022 | 1337 | 0.140 |
Why?
|
| Community Participation | 1 | 2017 | 38 | 0.140 |
Why?
|
| Language | 2 | 2015 | 158 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2793 | 0.140 |
Why?
|
| Videotape Recording | 1 | 2017 | 49 | 0.130 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 215 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2020 | 1511 | 0.130 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 25 | 0.130 |
Why?
|
| Sleep | 2 | 2023 | 462 | 0.130 |
Why?
|
| Bronchodilator Agents | 3 | 2024 | 66 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 41 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 88 | 0.130 |
Why?
|
| Internal Medicine | 2 | 2010 | 364 | 0.130 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.120 |
Why?
|
| Face | 1 | 2016 | 114 | 0.120 |
Why?
|
| Medicaid | 1 | 2019 | 248 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2016 | 91 | 0.120 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.120 |
Why?
|
| Motivation | 1 | 2018 | 309 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 34 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2016 | 103 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1594 | 0.120 |
Why?
|
| Acetates | 1 | 2015 | 69 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 59 | 0.120 |
Why?
|
| Translating | 1 | 2015 | 18 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2024 | 2976 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1118 | 0.120 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.120 |
Why?
|
| Androstadienes | 1 | 2015 | 73 | 0.120 |
Why?
|
| Quinolines | 1 | 2015 | 88 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 427 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 443 | 0.120 |
Why?
|
| Acute Disease | 1 | 2017 | 856 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 70 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2016 | 76 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 808 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 688 | 0.110 |
Why?
|
| Software | 1 | 2017 | 676 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 223 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 351 | 0.100 |
Why?
|
| Communication | 1 | 2016 | 463 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1150 | 0.090 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 180 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2025 | 8727 | 0.080 |
Why?
|
| Documentation | 2 | 2020 | 103 | 0.070 |
Why?
|
| Muscle Stretching Exercises | 1 | 2024 | 1 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2024 | 32 | 0.060 |
Why?
|
| Caregivers | 2 | 2017 | 177 | 0.060 |
Why?
|
| Medication Therapy Management | 1 | 2024 | 16 | 0.060 |
Why?
|
| Medicare Part C | 1 | 2024 | 7 | 0.060 |
Why?
|
| Postural Balance | 1 | 2024 | 50 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2024 | 60 | 0.060 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 35 | 0.060 |
Why?
|
| Actigraphy | 1 | 2024 | 60 | 0.050 |
Why?
|
| Walking | 1 | 2024 | 96 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 901 | 0.050 |
Why?
|
| Staff Development | 1 | 2023 | 28 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 152 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 807 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 197 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 205 | 0.040 |
Why?
|
| Sodium | 1 | 2021 | 335 | 0.040 |
Why?
|
| Efficiency | 1 | 2020 | 39 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 361 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 684 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 39 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 259 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 49 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 80 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 612 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 14 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 148 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 60 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 130 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 351 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 166 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 503 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 31 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 22 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 19 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 44 | 0.020 |
Why?
|
| Sick Leave | 1 | 2012 | 14 | 0.020 |
Why?
|
| Workplace | 1 | 2012 | 30 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 353 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2015 | 429 | 0.020 |
Why?
|
| Attention | 1 | 2016 | 403 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2502 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 253 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1661 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 335 | 0.020 |
Why?
|